Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nefopam for Postoperative Pain in VATS
NCT05173337Completed
- Sponsor
- Kangbuk Samsung Hospital
- Start
- Dec 2021
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of nefopam in postoperative pain (2 arms), sponsored by Kangbuk Samsung Hospital. Primary endpoints: Pain after 1 hour of surgery, Pain after 6 hour of surgery and 2 more. Started Dec 2021; status: completed.
02
Drugs
nefopam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05173337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05173337.